<DOC>
	<DOCNO>NCT01065766</DOCNO>
	<brief_summary>This survey conduct prepare application material re-examination Pharmaceutical Affairs Laws Enforcement Regulation , aim reconfirm clinical usefulness sitagliptin/metformin ( JANUMET ) collect safety efficacy information accord Re-examination Regulation New Drugs .</brief_summary>
	<brief_title>Sitagliptin/Metformin ( JANUMET ) Re-examination Study ( 0431A-182 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Has type 2 diabetes mellitus Is treat sitagliptin/metformin within local label first time Has contraindication sitagliptin/metformin accord local label Is treat sitagliptin/metformin contract enrollment period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Non-Insulin-Dependent</keyword>
</DOC>